Literature DB >> 12436367

Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.

H T Arkenau1, D O Stichtenoth, J C Frölich, M P Manns, K H W Böker.   

Abstract

Chronic liver diseases are accompanied by changes in splanchnic and systemic circulation. These changes are characterised by a reduction in peripheral vascular resistance and an increased cardiac output at rest. An increased release of nitric oxide (NO) has been proposed to play a role in the pathogenesis of vasodilatation and vascular hypocontractility. This study was designed to determine the nitric oxide metabolism measured as circulating nitrate levels in serum/urine in patients with chronic liver disease and cirrhosis. The nitrate concentrations were significantly increased in advanced degrees in cirrhosis Child B and C, and normal or even reduced in patients with chronic active hepatitis and early cirrhosis. In our study the connections between the extent of portal hypertension and nitrate levels were evident. The presence of ascites as well as the the progression of oesophageal varices were associated with higher circulating nitrate levels. The connection between increased nitric oxide production and the haemodynamic sequelae of portal hypertension is also apparent in the significant correlation between plasma renin and serum nitrate levels. Circulating nitrate levels also correlated to the serum interleukin-6 levels. This study demonstrated that the increased nitric oxide metabolism is associated with the haemodynamic alterations induced by portal hypertension.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12436367     DOI: 10.1055/s-2002-35413

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  13 in total

1.  Oxidative stress in portal hypertension-induced rats with particular emphasis on nitric oxide and trace metals.

Authors:  Titiz Izzet; Krand Osman; Unal Ethem; Yavuz Nihat; Kusaslan Ramazan; Dogan Mustafa; Uzun Hafize; Kiziler Ali Riza; Aydemir Birsen; Genc Habibe; Aydin Seval; Simsek Gonul
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

2.  Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial.

Authors:  Yaseen M Arabi; Abdulrahman Aljumah; Ousama Dabbagh; Hani M Tamim; Asgar H Rishu; Abdulmajeed Al-Abdulkareem; Bandar Al Knawy; Ali H Hajeer; Waleed Tamimi; Antoine Cherfan
Journal:  CMAJ       Date:  2010-11-08       Impact factor: 8.262

3.  Plasma nitrate/nitrite and endothelin-1 in patients with liver cirrhosis.

Authors:  Asli Curgunlu; Pervin Vural; Mukaddes Canbaz; Nilgun Erten; M Akif Karan; Cemil Tascioglu
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

4.  Lung diffusion capacity in early cirrhosis: is lung diffusion capacity a predictor of esophageal varices and ascites?

Authors:  Jun Young Jung; Dae Won Jun; Jae Hyung Lee
Journal:  Dig Dis Sci       Date:  2010-10-14       Impact factor: 3.199

5.  Serum levels of soluble Fas, nitric oxide and cytokines in acute decompensated cirrhotic patients.

Authors:  Christoph Elsing; Sabine Harenberg; Wolfgang Stremmel; Thomas Herrmann
Journal:  World J Gastroenterol       Date:  2007-01-21       Impact factor: 5.742

6.  Could serum nitrate and nitrite levels possibly predict hepatorenal syndrome in hepatitis C virus-related liver cirrhosis?

Authors:  Waheed Abdelmonsef Mahmoud; Nadia Abdelaaty Abdelkader; Amal Mansor
Journal:  Indian J Gastroenterol       Date:  2013-11-29

7.  Nitric oxide levels in chronic liver disease patients with and without oesophageal varices.

Authors:  Assem M El-Sherif; Mohamed A Abou-Shady; Ashraf M Al-Bahrawy; Reda M Bakr; Abdel-Moneim M Hosny
Journal:  Hepatol Int       Date:  2008-04-22       Impact factor: 6.047

Review 8.  KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2018-07-09

9.  The effects of trimetazidine on lipopolysaccharide-induced oxidative stress in mice.

Authors:  Omar M E Abdel-Salam; Nadia A Mohammed; Amany A Sleem
Journal:  EXCLI J       Date:  2011-10-10       Impact factor: 4.068

10.  Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis.

Authors:  María García-Fernández; Inma Castilla-Cortázar; Matías Díaz-Sanchez; Iñigo Navarro; Juan Enrique Puche; Alberto Castilla; Amelia Díaz Casares; Encarna Clavijo; Salvador González-Barón
Journal:  BMC Gastroenterol       Date:  2005-03-03       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.